CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
+10.54 (+3.86%)283.95USD274K成交股數13.6B市值–本益比(近四季)3.4股價營收比-2.7%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.0B-3% | 996M+1% | 994M-1% | 1.0B-0% | 1.0B+1% | 984M-3% | 1.0B-2% | 1.0B-5% | 1.0B | 1.0B | 1.0B | 1.1B |
| 營業成本 | – | – | – | – | – | – | – | 661M | 672M | 667M | 665M | 661M |
| 毛利 | – | – | – | – | – | – | – | 349M-13% | 354M | 345M | 362M | 399M |
| 毛利率 | – | – | – | – | – | – | – | 34.6% | 34.5% | 34.1% | 35.2% | 37.6% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 229M | 159M | 196M | 178M | 192M | 178M | 196M | 199M | 170M | 186M | 176M | 200M |
| 營業利益 | 120M+20% | 120M+61% | −283M+69% | 134M+14% | 100M-34% | 74.7M-41% | −168M-211% | 117M-29% | 152M | 126M | 152M | 165M |
| 營業利益率 | 11.9% | 12.0% | -28.5% | 13.3% | 9.7% | 7.6% | -16.7% | 11.6% | 14.8% | 12.5% | 14.8% | 15.6% |
| 稅後淨利 | −1.5M-103% | −14.8M-158% | −277M+29% | 54.4M-22% | 52.3M-44% | 25.5M-65% | −214M-345% | 69.7M-28% | 94.1M | 73.0M | 87.4M | 97.0M |
| 淨利率 | -0.1% | -1.5% | -27.8% | 5.4% | 5.1% | 2.6% | -21.4% | 6.9% | 9.2% | 7.2% | 8.5% | 9.2% |
| 稀釋 EPS | -0.03-103% | -0.30-160% | -5.57+34% | 1.10-17% | 1.06-39% | 0.50-62% | -4.17-347% | 1.33-30% | 1.74 | 1.30 | 1.69 | 1.89 |
| 稀釋股數 | 48.0M | 49.0M | 49.6M | 49.4M | 49.3M | 50.9M | 51.6M | 51.6M | 51.8M | 51.8M | 51.6M | 51.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 192M | 192M | 214M | 207M | 183M | 229M | 195M | 210M | 179M | 327M | 157M | 200M |
| 應收帳款 | 712M | 700M | 709M | 734M | 768M | 757M | 721M | 754M | 762M | 787M | 799M | 801M |
| 存貨 | 346M | 360M | 299M | 303M | 280M | 290M | 279M | 336M | 349M | 361M | 293M | 285M |
| 總資產 | 7.5B | 7.7B | 7.1B | 7.5B | 7.6B | 7.6B | 7.5B | 8.0B | 7.9B | 8.2B | 7.6B | 7.8B |
| 有息負債 | 2.6B | 2.7B | 2.1B | 2.2B | 2.3B | 2.5B | 2.2B | 2.3B | 2.4B | 2.7B | 2.5B | 2.7B |
| 總負債 | 4.6B | 4.7B | 3.9B | 4.1B | 4.2B | 4.3B | 4.0B | 4.2B | 4.2B | 4.4B | 4.3B | 4.5B |
| 股東權益 | 2.8B | 2.9B | 3.2B | 3.4B | 3.4B | 3.2B | 3.5B | 3.8B | 3.7B | 3.6B | 3.3B | 3.3B |
| 負債比 | 61.7% | 61.3% | 55.0% | 54.1% | 55.0% | 57.2% | 53.4% | 52.2% | 52.5% | 54.6% | 56.0% | 57.5% |
| 淨現金(現金 − 有息負債) | −2.4B | −2.5B | −1.9B | −2.0B | −2.1B | −2.3B | −2.0B | −2.1B | −2.2B | −2.3B | −2.4B | −2.5B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 41.1M-76% | – | – | – | 172M+32% | – | – | – | 130M | – | – |
| 資本支出 | – | 55.9M | 89.0M | 35.6M | 35.3M | 59.3M | 75.6M | 38.7M | 39.5M | 79.1M | 65.9M | 67.4M |
| 自由現金流 | – | −14.8M-113% | – | – | – | 112M+121% | – | – | – | 50.7M | – | – |
| 折舊攤銷 | 67.3M | 67.2M | 78.3M | 85.2M | 120M | 120M | 102M | 88.2M | 86.1M | 85.4M | 78.9M | 77.7M |
| 買回庫藏股 | – | 208M | – | – | – | 353M | – | – | – | 9.4M | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -1.5% | – | – | – | 11.4% | – | – | – | 5.0% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 4.0B
| Discovery And Safety Assessment | 2.4B | 59.8% | -2.0% |
|---|---|---|---|
| Research Models And Services | 846M | 21.1% | +2.0% |
| Manufacturing Support | 766M | 19.1% | -0.4% |
地區2025 年度 · 4.0B
| 美國 | 2.1B | 53.3% | -4.4% |
|---|---|---|---|
| 歐洲 | 1.1B | 27.5% | +2.3% |
| 加拿大 | 501M | 12.5% | +3.9% |
| 亞太 | 205M | 5.1% | +4.1% |
| 其他 | 64.9M | 1.6% | +22.8% |
產品／服務2025 年度 · 4.0B
| 服務 | 3.3B | 80.9% | -1.6% |
|---|---|---|---|
| 產品 | 765M | 19.1% | +2.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 4.0B | -0.9% | −144M | -3.6% | -2.91 | 518M |
| FY2024 | 4.0B | -1.9% | 22.2M | 0.5% | 0.20 | 502M |
| FY2023 | 4.1B | +3.9% | 475M | 11.5% | 9.22 | 365M |
| FY2022 | 4.0B | +12.3% | 486M | 12.2% | 9.48 | 295M |
| FY2021 | 3.5B | +21.1% | 391M | 11.0% | 7.60 | 532M |
| FY2020 | 2.9B | +11.5% | 364M | 12.5% | 7.20 | 380M |
| FY2019 | 2.6B | +15.7% | 252M | 9.6% | 5.07 | 340M |
| FY2018 | 2.3B | – | 226M | 10.0% | 4.62 | 301M |